Perry Watts
Impact in
- Oncology top 5%
- Peptidase Inhibition and Analysis
- Cancer Research top 10%
- Protease and Inhibitor Mechanisms
Papers in
-
- vaccines and immunoinformatics approaches 2
- Polyamine Metabolism and Applications 2
- Oncology 4
- Peptidase Inhibition and Analysis 2
- Co-authors
- Samuel Litwin (7 shared papers)Eric A. Ross (3 shared papers)Andres J. Klein–Szanto (4 shared papers)Jonathan D. Cheng (2 shared papers)Leonard R. Henry (3 shared papers)John S. Lee (1 shared paper)Hyung‐Ok Lee (1 shared paper)Wen‐Tien Chen (1 shared paper)
- Journals
- Journal of Clinical Oncology (3 papers)Journal of Cellular Biochemistry (1 paper)Clinical Cancer Research (1 paper)Molecular Immunology (1 paper)Carcinogenesis (1 paper)
- Partner nations
- United States
In The Last Decade
Perry Watts
18 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 104
- Oncology 436
- Cancer Research 169
- Immunology 185
- Pulmonary and Respiratory Medicine 199
- Radiology, Nuclear Medicine and Imaging 138
Countries citing papers authored by Perry Watts
This map shows the geographic impact of Perry Watts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Perry Watts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Perry Watts more than expected).
Fields of papers citing papers by Perry Watts
This network shows the impact of papers produced by Perry Watts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Perry Watts. The network helps show where Perry Watts may publish in the future.
Co-authors
The 25 scholars most cited alongside Perry Watts, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 312 | |
| 2 | 1992 | 213 | |
| 3 | 1997 | 143 | |
| 4 | 2007 | 113 | |
| 5 | A human tumor xenograft model of therapy with a bispecific monoclonal antibody targeting c-erbB-2 and CD16. | 1993 | 62 |
| 6 | 1998 | 46 | |
| 7 | 2001 | 36 | |
| 8 | Women's responses to the mammography experience. | 1994 | 32 |
| 9 | 2006 | 31 | |
| 10 | 1992 | 26 | |
| 11 | Phase I evaluation of combination therapy with interleukin 2 and gamma-interferon. | 1991 | 22 |
| 12 | 1997 | 13 | |
| 13 | 1991 | 10 | |
| 14 | Effects of formaldehyde on normal xenotransplanted human tracheobronchial epithelium. | 1989 | 10 |
| 15 | Association between high levels of ornithine decarboxylase activity and favorable prognosis in human colorectal carcinoma. | 1995 | 7 |
| 16 | 1993 | 5 | |
| 17 | 2005 | 2 | |
| 18 | 2005 | 1 |
About Perry Watts
Perry Watts is a scholar working on Molecular Biology, Oncology, Radiology, Nuclear Medicine and Imaging, Immunology and Public Health, Environmental and Occupational Health, having authored 18 papers that have together received 1.1k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (3 papers), T-cell and B-cell Immunology (2 papers), Toxin Mechanisms and Immunotoxins (2 papers), Peptidase Inhibition and Analysis (2 papers), Ethics in Clinical Research (2 papers), vaccines and immunoinformatics approaches (2 papers), Polyamine Metabolism and Applications (2 papers) and Folate and B Vitamins Research (1 paper). The work is most often cited by research in Oncology (436 citations), Cancer Research (169 citations), Immunology (185 citations), Pulmonary and Respiratory Medicine (199 citations) and Radiology, Nuclear Medicine and Imaging (138 citations). Perry Watts has collaborated with scholars based in United States. Frequent co-authors include Samuel Litwin, Eric A. Ross, Andres J. Klein–Szanto, Jonathan D. Cheng, Leonard R. Henry, John S. Lee, Hyung‐Ok Lee, Wen‐Tien Chen, Jeffrey J Stewart and Mark J. Shlomchik. Their work appears in journals such as Journal of Clinical Oncology, Journal of Cellular Biochemistry, Clinical Cancer Research, Molecular Immunology and Carcinogenesis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.